Peter Lewindon

3.9k total citations
92 papers, 2.2k citations indexed

About

Peter Lewindon is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Peter Lewindon has authored 92 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Surgery, 34 papers in Pulmonary and Respiratory Medicine and 27 papers in Genetics. Recurrent topics in Peter Lewindon's work include Inflammatory Bowel Disease (20 papers), Pediatric Hepatobiliary Diseases and Treatments (19 papers) and Cystic Fibrosis Research Advances (19 papers). Peter Lewindon is often cited by papers focused on Inflammatory Bowel Disease (20 papers), Pediatric Hepatobiliary Diseases and Treatments (19 papers) and Cystic Fibrosis Research Advances (19 papers). Peter Lewindon collaborates with scholars based in Australia, United States and New Zealand. Peter Lewindon's co-authors include Zubin Grover, Grant A. Ramm, Ross W. Shepherd, Richard Muir, Tamara N. Pereira, Ristan M. Greer, G. J. Cleghorn, Anita C. Hoskins, Richard Williamson and Jeremy Rajanayagam and has published in prestigious journals such as Gastroenterology, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Peter Lewindon

88 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Lewindon Australia 28 890 736 679 608 427 92 2.2k
B. A. Chapman New Zealand 23 762 0.9× 232 0.3× 740 1.1× 485 0.8× 309 0.7× 44 2.0k
C. M. A. Bijleveld Netherlands 32 1.5k 1.7× 409 0.6× 684 1.0× 152 0.3× 933 2.2× 99 2.6k
Girish Gupte United Kingdom 20 736 0.8× 237 0.3× 509 0.7× 155 0.3× 411 1.0× 109 2.0k
Carmen Cuffari United States 22 590 0.7× 175 0.2× 433 0.6× 730 1.2× 73 0.2× 71 1.7k
Amanda Ricciuto Canada 17 849 1.0× 127 0.2× 1.3k 1.9× 1.7k 2.8× 240 0.6× 44 2.4k
Barbara E. Wildhaber Switzerland 26 1.6k 1.8× 800 1.1× 351 0.5× 147 0.2× 409 1.0× 123 2.5k
Stéphanie Van Biervliet Belgium 23 572 0.6× 582 0.8× 222 0.3× 201 0.3× 62 0.1× 134 1.7k
Jarosław Kierkuś Poland 25 808 0.9× 114 0.2× 1.0k 1.5× 1.4k 2.2× 154 0.4× 186 2.7k
Javier Bueno Spain 32 1.6k 1.8× 206 0.3× 402 0.6× 211 0.3× 659 1.5× 113 3.2k
Robert C. Harland United States 28 1.8k 2.0× 322 0.4× 317 0.5× 357 0.6× 512 1.2× 86 3.4k

Countries citing papers authored by Peter Lewindon

Since Specialization
Citations

This map shows the geographic impact of Peter Lewindon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lewindon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lewindon more than expected).

Fields of papers citing papers by Peter Lewindon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lewindon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lewindon. The network helps show where Peter Lewindon may publish in the future.

Co-authorship network of co-authors of Peter Lewindon

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lewindon. A scholar is included among the top collaborators of Peter Lewindon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lewindon. Peter Lewindon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reilly, C.M., et al.. (2025). The use of oral antibiotic cocktail in medically refractory paediatric acute severe colitis: a case series. European Journal of Gastroenterology & Hepatology. 37(5). 594–599.
2.
Saha, Amit, et al.. (2025). Cystic fibrosis-related liver disease in children- A vascular or a biliary disease?. Journal of Cystic Fibrosis. 24(6). 1143–1148.
3.
Colombo, Carla, Grant A. Ramm, Anders Lindblad, et al.. (2023). Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators. Journal of Cystic Fibrosis. 22(2). 263–265. 4 indexed citations
4.
Colombo, Carla, Gianfranco Alicandro, Mark Oliver, et al.. (2021). Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study. Journal of Cystic Fibrosis. 21(2). 220–226. 21 indexed citations
5.
Burgess, Christopher, et al.. (2021). 181 PAEDIATRIC PRIMARY SCLEROSING CHOLANGITIS-ULCERATIVE COLITIS.AUDIT OF 2 YEAR OUTCOME WITH ORAL VANCOMYCIN TREATMENT.. Gastroenterology. 160(6). S–44. 2 indexed citations
6.
Johnson, Douglas, John Halliday, Robert V. Bryant, et al.. (2021). SARS‐CoV‐2 vaccination in patients with inflammatory bowel disease. PubMed. 3(4). 212–228. 8 indexed citations
7.
Carman, Nicholas, Richard Muir, & Peter Lewindon. (2019). Ferric carboxymaltose in the treatment of iron deficiency in pediatric inflammatory bowel disease. Translational Pediatrics. 8(1). 28–34. 18 indexed citations
8.
Grover, Zubin, Christopher Burgess, Richard Muir, C.M. Reilly, & Peter Lewindon. (2016). Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn’s disease. Journal of Crohn s and Colitis. 10(10). 1159–1164. 68 indexed citations
9.
Coman, David, Peter Lewindon, Peter T. Clayton, & Kate Riney. (2015). PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?. JIMD Reports. 25. 71–75. 17 indexed citations
10.
Wright, Emily K., James S. Williams, Jane M. Andrews, et al.. (2014). Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease. Internal Medicine Journal. 44(5). 490–496. 48 indexed citations
11.
Doecke, James D., Lisa A. Simms, Zhen Zhao, et al.. (2013). Genetic Susceptibility in IBD. Inflammatory Bowel Diseases. 19(2). 240–245. 35 indexed citations
12.
Hill, Rebecca J., Peter Lewindon, Frances Connor, et al.. (2010). Ability of commonly used prediction equations to predict resting energy expenditure in children with inflammatory bowel disease. Inflammatory Bowel Diseases. 17(7). 1587–1593. 16 indexed citations
13.
Sullivan, Peter, Peter Lewindon, Peter F. Lenehan, et al.. (2007). Intestinal mucosa remodeling by recombinant human epidermal growth factor1-48 in neonates with severe necrotizing enterocolitis. Journal of Pediatric Surgery. 42(3). 462–469. 32 indexed citations
14.
Chang, Anne B., Nancy Cox, Joan Faoagali, et al.. (2006). Cough and reflux esophagitis in children: their co-existence and airway cellularity. BMC Pediatrics. 6(1). 4–4. 19 indexed citations
15.
Buntain, Helen M., Ristan M. Greer, J. Wong, et al.. (2005). Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis. Journal of Paediatrics and Child Health. 41(7). 317–322. 32 indexed citations
16.
Ramm, Grant A., Anita C. Hoskins, Sonia A. Greco, Tamara N. Pereira, & Peter Lewindon. (2004). Signals for Hepatic Figrogenesis in Pediatric Cholestatic Liver Disease: Review and Hypothesis. PubMed. 3(S1). S5–S5. 13 indexed citations
17.
Thompson, Richard J., et al.. (2004). Cholestatic and metabolic liver diseases: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004;39: S611-15.. Journal of Pediatric Gastroenterology and Nutrition. 39. 1 indexed citations
18.
Ee, Looi C., Ross W. Shepherd, G. J. Cleghorn, et al.. (2003). Acute liver failure in children : a regional experience. Queensland's institutional digital repository (The University of Queensland). 1 indexed citations
19.
Greer, Ristan M., et al.. (2003). Body Composition and Components of Energy Expenditure in Children With End‐ Stage Liver Disease. Journal of Pediatric Gastroenterology and Nutrition. 36(3). 358–363. 17 indexed citations
20.
Lewindon, Peter, Tamara N. Pereira, Anita C. Hoskins, et al.. (2002). The Role of Hepatic Stellate Cells and Transforming Growth Factor-β1 in Cystic Fibrosis Liver Disease. American Journal Of Pathology. 160(5). 1705–1715. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. A. Chapman Breakdown of academic impact, for papers by C. M. A. Bijleveld Breakdown of academic impact, for papers by Girish Gupte Breakdown of academic impact, for papers by Carmen Cuffari Breakdown of academic impact, for papers by Amanda Ricciuto Breakdown of academic impact, for papers by Barbara E. Wildhaber Breakdown of academic impact, for papers by Stéphanie Van Biervliet Breakdown of academic impact, for papers by Jarosław Kierkuś Breakdown of academic impact, for papers by Javier Bueno Breakdown of academic impact, for papers by Robert C. Harland
Rankless by CCL
2026